In test set of GSE132903, the expression level of IGF1 was significantly down-regulated in temporal lobes of 97 AD patients (5.38 ± 0.54) compared with 98 non-dementia controls (5.67 ± 0.45; p < 0.0001) (Figure 2(a)). Here, IGF1 is linked to Alzheimer disease.